These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Effects of propafenone on slow response action potential and the slow inward current of the myocardium]. Xu YQ; Liu YM; Gao RB; Mei YA; Xu JM Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):138-40. PubMed ID: 2946151 [No Abstract] [Full Text] [Related]
9. Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres. Tamargo J; Delgado C Eur J Pharmacol; 1985 Dec; 118(3):331-40. PubMed ID: 4085559 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone. von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue. Damiano BP; Brannan MD J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397 [TBL] [Abstract][Full Text] [Related]
12. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity. Damiano BP; Stump GL; Yagel SK J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of propafenone on canine ischemic cardiac cells. Zeiler RH; Gough WB; El-Sherif N Am J Cardiol; 1984 Aug; 54(3):424-9. PubMed ID: 6465028 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects of AHR 10718 on isolated cardiac tissues. Damiano BP; Le Marec H; Rosen MR Eur J Pharmacol; 1985 Feb; 108(3):243-55. PubMed ID: 3838726 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart. Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472 [TBL] [Abstract][Full Text] [Related]
16. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog. Boucher M; Chassaing C; Hamel JD; Poirier JM Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations. Sunami A; Sawanobori T; Adaniya H; Hiraoka M Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258 [TBL] [Abstract][Full Text] [Related]
18. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification. Zaza A; Malfatto G; Schwartz PJ J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840 [TBL] [Abstract][Full Text] [Related]
19. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. Li T; Carr AA; Dage RC J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984 [TBL] [Abstract][Full Text] [Related]
20. Effects of propafenone on sinus nodal and ventricular automaticity: in vitro and in vivo correlation. Katoh T; Karagueuzian HS; Sugi K; Ohta M; Mandel WJ; Peter T Am Heart J; 1987 Apr; 113(4):941-52. PubMed ID: 3565244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]